How do I apply?
All applications submitted to NIH must be submitted electronically on the SF424 (R&R) via grants.gov. Instructions are located within each Funding Opportunity Announcement (FOA).
What is the SF424 form (R & R)?
The SF424 Research and Research Related (R&R) application form was developed for all Federal Agencies involved in research and research-related grant funding.
Grants.gov provides a single interface for all agencies to announce their grant opportunities and for all grant applicants to find and apply for those opportunities.
In what areas of research is NIDDK interested?
The NIDDK welcomes SBIR and STTR applications from small businesses in any biomedical or behavioral research area that falls within our mission. A sampling of areas of interest are described in the annual omnibus solicitation (PDF); this is NOT a comprehensive list.
Does my application compete with other NIH programs for funding?
No. The funds for this program are 'set-aside' and therefore do not compete with the regular research, training, or other special programs supported by the Institute. The SBIR set-aside in 2014 is 2.8% of the budget; The STTR program has a 2014 set-aside of 0.40%.
What is the difference between an SBIR and an STTR?
The Principal Investigator must have his/her primary employment (>51%) with the small business on an SBIR grant; STTR applicants are REQUIRED to have a formal collaborative relationship with a research institution in the performance of the project that will lead to a commercial product. For more information see eligibility.
Am I permitted to submit a Phase II application if I have not yet received my Phase I award?
No. Small business concerns that have received an SBIR Phase I grant or an STTR Phase I grant are eligible to apply for SBIR or STTR Phase II funding, respectively, of that program. In the Spring of 2014 NIH will pilot "direct to Phase II" application using targeted FOA by a few of the NIH institutes.
Are there limits on costs and length of time the project can last?
|SBIR (R43/44) and STTR (R41/R42)
|Phase I may not exceed $225,000 (DC, F&A, and fee) and one year.
|Phase II may not exceed $1,500,000 (DC, F&A, and fee) and 2 years.
Is there a way to get funded for Phase I and II at the same time?
Yes. A Fast-Track allows the submission and review of Phase I and II applications at the same time.
Can I track my application throughout the NIH process?
Yes. eRA Commons allows you access to your application(s) at all phases of the process and funded grant status post award.
Can I take my grant with me if I move?
Awards are issued to the small business, not the PI. If the business that holds the award is unable or unwilling to do the research without you and you are moving to another eligible small company, it is possible to move the grant. NIDDK considers such situations on a case by case basis.
What is the Commercialization Assessment Program (CAP)?
A program of training workshops, individual mentoring and consulting sessions for Phase II awardees, designed to help some of the nation’s most promising life science startups develop their commercial business. See NIH CAP for more information.
How can I find out about SBIR/STTR-related information?
By subscribing to the NIH listserv for small business-related information-SBIR/STTR LISTSERV – you will receive all updates as they are issued.
* Documents in PDF format require the free Adobe Acrobat Reader application for viewing.